• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏CDH1基因改变的乳腺浸润性小叶癌的基因组和表观基因组基础。

Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations.

作者信息

Dopeso Higinio, Gazzo Andrea M, Derakhshan Fatemeh, Brown David N, Selenica Pier, Jalali Sahar, Da Cruz Paula Arnaud, Marra Antonio, da Silva Edaise M, Basili Thais, Gusain Laxmi, Colon-Cartagena Lorraine, Bhaloo Shirin Issa, Green Hunter, Vanderbilt Chad, Oesterreich Steffi, Grabenstetter Anne, Kuba M Gabriela, Ross Dara, Giri Dilip, Wen Hannah Y, Zhang Hong, Brogi Edi, Weigelt Britta, Pareja Fresia, Reis-Filho Jorge S

机构信息

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.

出版信息

NPJ Precis Oncol. 2024 Feb 12;8(1):33. doi: 10.1038/s41698-024-00508-x.

DOI:10.1038/s41698-024-00508-x
PMID:38347189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10861500/
Abstract

CDH1 (E-cadherin) bi-allelic inactivation is the hallmark alteration of breast invasive lobular carcinoma (ILC), resulting in its discohesive phenotype. A subset of ILCs, however, lack CDH1 genetic/epigenetic inactivation, and their genetic underpinning is unknown. Through clinical targeted sequencing data reanalysis of 364 primary ILCs, we identified 25 ILCs lacking CDH1 bi-allelic genetic alterations. CDH1 promoter methylation was frequent (63%) in these cases. Targeted sequencing reanalysis revealed 3 ILCs harboring AXIN2 deleterious fusions (n = 2) or loss-of-function mutation (n = 1). Whole-genome sequencing of 3 cases lacking bi-allelic CDH1 genetic/epigenetic inactivation confirmed the AXIN2 mutation and no other cell-cell adhesion genetic alterations but revealed a new CTNND1 (p120) deleterious fusion. AXIN2 knock-out in MCF7 cells resulted in lobular-like features, including increased cellular migration and resistance to anoikis. Taken together, ILCs lacking CDH1 genetic/epigenetic alterations are driven by inactivating alterations in other cell adhesion genes (CTNND1 or AXIN2), endorsing a convergent phenotype in ILC.

摘要

CDH1(E-钙黏蛋白)双等位基因失活是乳腺浸润性小叶癌(ILC)的标志性改变,导致其出现分散的表型。然而,一部分ILC缺乏CDH1基因/表观遗传失活,其遗传基础尚不清楚。通过对364例原发性ILC的临床靶向测序数据进行重新分析,我们鉴定出25例缺乏CDH1双等位基因遗传改变的ILC。在这些病例中,CDH1启动子甲基化很常见(63%)。靶向测序重新分析发现3例ILC携带AXIN2有害融合(n = 2)或功能丧失突变(n = 1)。对3例缺乏CDH1双等位基因遗传/表观遗传失活的病例进行全基因组测序,证实了AXIN2突变,且未发现其他细胞间黏附基因改变,但发现了一种新的CTNND1(p120)有害融合。在MCF7细胞中敲除AXIN2会导致小叶样特征,包括细胞迁移增加和对失巢凋亡的抗性增强。综上所述,缺乏CDH1基因/表观遗传改变的ILC是由其他细胞黏附基因(CTNND1或AXIN2)的失活改变驱动的,这支持了ILC中的趋同表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/5564965e5a96/41698_2024_508_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/45d46e88a3f5/41698_2024_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/27463382ec1f/41698_2024_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/81ef6418a1d4/41698_2024_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/83d3856f4c2c/41698_2024_508_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/5564965e5a96/41698_2024_508_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/45d46e88a3f5/41698_2024_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/27463382ec1f/41698_2024_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/81ef6418a1d4/41698_2024_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/83d3856f4c2c/41698_2024_508_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8129/10861500/5564965e5a96/41698_2024_508_Fig5_HTML.jpg

相似文献

1
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations.缺乏CDH1基因改变的乳腺浸润性小叶癌的基因组和表观基因组基础。
NPJ Precis Oncol. 2024 Feb 12;8(1):33. doi: 10.1038/s41698-024-00508-x.
2
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.小叶性乳腺癌中APC和CDH1基因的表观遗传和遗传改变:与E-钙黏蛋白和连环蛋白异常表达及微卫星不稳定性的关系
Int J Cancer. 2003 Aug 20;106(2):208-15. doi: 10.1002/ijc.11197.
3
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.具有双等位基因致病性 CDH1 体细胞改变的非小叶状浸润性乳腺癌:组织学、免疫表型和基因组特征。
Mod Pathol. 2024 Feb;37(2):100375. doi: 10.1016/j.modpat.2023.100375. Epub 2023 Nov 3.
4
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?小叶样浸润性乳腺癌的临床病理及基因组特征:它是一种独特的实体吗?
NPJ Breast Cancer. 2023 Jul 13;9(1):60. doi: 10.1038/s41523-023-00566-7.
5
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.E-钙黏蛋白在乳腺浸润性小叶癌中的免疫组化表达:与形态学和 CDH1 体细胞改变的相关性。
Hum Pathol. 2020 Aug;102:44-53. doi: 10.1016/j.humpath.2020.06.002. Epub 2020 Jun 26.
6
Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.非肿瘤性上皮中的表观遗传沉默将E-钙黏蛋白(CDH1)确定为小叶瘤化学预防的靶点。
J Pathol. 2009 Jun;218(2):265-72. doi: 10.1002/path.2541.
7
CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.分析有基因突变和无基因突变的浸润性小叶乳腺癌中 CDH1 的甲基化。
Virchows Arch. 2024 Aug;485(2):291-297. doi: 10.1007/s00428-024-03814-8. Epub 2024 May 7.
8
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.沉默乳腺小叶癌中E-钙黏蛋白基因表达的多种方式。
Int J Cancer. 2001 May 1;92(3):404-8. doi: 10.1002/ijc.1208.
9
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms.基于基因组驱动的人工智能模型对乳腺浸润性小叶癌进行分类,并发现 CDH1 失活机制。
Cancer Res. 2024 Oct 15;84(20):3478-3489. doi: 10.1158/0008-5472.CAN-24-1322.
10
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.ERBB2突变与CDH1改变的乳腺浸润性小叶癌患者的预后较差相关。
Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019.

引用本文的文献

1
Unmasking hidden metastasis: A case report of gastrointestinal metastasis detected a decade after breast cancer diagnosis.揭示隐匿性转移:一例乳腺癌诊断十年后发现胃肠道转移的病例报告。
Medicine (Baltimore). 2025 Aug 8;104(32):e43893. doi: 10.1097/MD.0000000000043893.
2
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast.乳腺浸润性小叶癌形态学变异型的组织学诊断陷阱
Mod Pathol. 2025 Jul 3;38(9):100837. doi: 10.1016/j.modpat.2025.100837.
3
Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management.

本文引用的文献

1
Uncovering novel mutational signatures by extraction with SigProfilerExtractor.通过SigProfilerExtractor提取来揭示新的突变特征。
Cell Genom. 2022 Nov 9;2(11):None. doi: 10.1016/j.xgen.2022.100179.
2
() Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story.()人类乳腺癌中的基因甲基化:对一个漫长而曲折故事的批判性评估。
Cancers (Basel). 2022 Sep 8;14(18):4377. doi: 10.3390/cancers14184377.
3
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
小叶型乳腺癌的独特分子改变:与病理分类、肿瘤生物学行为及临床管理的关联
Cancers (Basel). 2025 Jan 27;17(3):417. doi: 10.3390/cancers17030417.
4
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.解析罕见乳腺癌亚型的复杂性并把握机遇。
NPJ Breast Cancer. 2025 Jan 24;11(1):6. doi: 10.1038/s41523-025-00719-w.
5
Molecular Basis of Breast Tumor Heterogeneity.乳腺肿瘤异质性的分子基础
Adv Exp Med Biol. 2025;1464:237-257. doi: 10.1007/978-3-031-70875-6_13.
6
Insights into E-Cadherin Impairment in -Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic Study.探讨未改变的浸润性小叶癌中 E-钙黏蛋白损伤的机制:一项全面的生物信息学研究。
Int J Mol Sci. 2024 Aug 17;25(16):8961. doi: 10.3390/ijms25168961.
7
E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.E-钙黏蛋白染色在乳腺小叶与导管肿瘤诊断中的应用:皇帝没穿衣服。
Histopathology. 2025 Feb;86(3):327-340. doi: 10.1111/his.15295. Epub 2024 Aug 13.
8
Case report: Characterization of the immunologic and molecular landscape in a unique presentation of invasive lobular carcinoma with concurrent uterine carcinosarcoma treated with immunotherapy.病例报告:免疫和分子特征分析——同时患有子宫内膜癌肉瘤的浸润性小叶癌的独特表现,并接受免疫治疗。
Front Immunol. 2024 Jul 15;15:1422342. doi: 10.3389/fimmu.2024.1422342. eCollection 2024.
9
CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.分析有基因突变和无基因突变的浸润性小叶乳腺癌中 CDH1 的甲基化。
Virchows Arch. 2024 Aug;485(2):291-297. doi: 10.1007/s00428-024-03814-8. Epub 2024 May 7.
APOBEC 诱变、kataegis、EGFR 突变奥希替尼耐药肺腺癌中的染色体重排。
Ann Oncol. 2022 Dec;33(12):1284-1295. doi: 10.1016/j.annonc.2022.09.151. Epub 2022 Sep 9.
4
Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.宫颈透明细胞癌中 WWTR1 S89W 突变的反复出现和 Hippo 通路的失调。
J Pathol. 2022 Aug;257(5):635-649. doi: 10.1002/path.5910. Epub 2022 May 20.
5
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.乳腺癌浸润性小叶癌患者中癌症易感性基因的种系致病性变异。
J Clin Oncol. 2021 Dec 10;39(35):3918-3926. doi: 10.1200/JCO.21.00640. Epub 2021 Oct 21.
6
Familial colorectal cancer and tooth agenesis caused by an AXIN2 variant: how do we detect families with rare cancer predisposition syndromes?AXIN2 变异导致的家族性结直肠癌和牙齿缺失:我们如何检测具有罕见癌症易感性综合征的家族?
Fam Cancer. 2022 Jul;21(3):325-332. doi: 10.1007/s10689-021-00280-y. Epub 2021 Oct 12.
7
GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing.GRIDSS2:利用单断点变体和结构变异相位进行体细胞结构变异的全面特征描述。
Genome Biol. 2021 Jul 12;22(1):202. doi: 10.1186/s13059-021-02423-x.
8
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.化生性乳腺癌中的端粒酶逆转录酶(TERT)启动子热点突变与基因扩增
NPJ Breast Cancer. 2021 Apr 16;7(1):43. doi: 10.1038/s41523-021-00250-8.
9
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.精准放疗:30 个 ROC 试验中减少口咽癌的放射剂量。
J Natl Cancer Inst. 2021 Jun 1;113(6):742-751. doi: 10.1093/jnci/djaa184.
10
Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.乳腺浸润性小叶癌:这种特殊亚型的重要性日益增加。
Breast Cancer Res. 2021 Jan 7;23(1):6. doi: 10.1186/s13058-020-01384-6.